. 2016 Sep 8;4:e2448. doi: 10.7717/peerj.2448

Table 3. Associations for urinary cotinine, arsenic, and phthalates (μg/l) with cervical cancer therapy response, adjusted for covariates using multiple linear regression models.^a.

Predictors	n	β	95%	CI	P-value
Cotinine	37	−0.001	−0.005	0.003	0.590
Arsenic	37	0.005	−0.002	0.013	0.173
MBP	35	0.0003	−0.001	0.002	0.752
MBzP	35	−0.001	−0.013	0.010	0.831
MEHP	35	0.0007	−0.006	0.007	0.817
MEOHP	35	−0.016	−0.044	0.012	0.256
MEHHP	35	0.0006	−0.006	0.007	0.855
%MEHP^b	35	0.015	0.003	0.03	0.019

Notes.

Adjusted for baseline tumor size (cm), age (years), urinary creatinine (mg/l), and urinary cotinine for arsenic and phthalates (μg/l).

%MEHP = 100 × (MEHP/(MEHP + MEOHP + MEHHP)) on a molar basis.

Table 3. Associations for urinary cotinine, arsenic, and phthalates (μg/l) with cervical cancer therapy response, adjusted for covariates using multiple linear regression models.a.